Mark Your Calendar for the Upcoming SOT Contemporary Concepts in Toxicology Conferences


By Ruth Roberts posted 09-14-2017 14:56


The Society of Toxicology (SOT) is pleased to offer three Contemporary Concepts in Toxicology (CCT) conferences in the coming year. Please visit the SOT website for further details and registration for these upcoming CCT conferences.

Building a Better Epithelium, Breaking the Barrier to the Next Generation of Toxicity Testing, March 10, 2018, San Antonio, Texas

BBE image.pngThis meeting will provide opportunities for toxicologists who are interested in, or currently using, organotypic models and technology developers to meet face-to-face to foster collaborations that will move the field forward. Hear Keynote Speaker, Mina Bissell, PhD, from Lawrence Berkley National Laboratory present “Context is Everything: Thinking Outside the Box on the Form and Function of Epithelium.”   

Toxicological Concerns in Older Adults, a Neglected Majority, March 10, 2018, San Antonio, Texas

Aging Image.pngBy the year 2050, more than one in every five persons is projected to be aged 60 or over. Although considerable effort has been spent addressing the biological aspects of aging, including genetics and pharmacology, toxicological effects specific to older populations have been understudied. The primary goal of this meeting is to increase understanding of the changes associated with the aging process and discuss ways in which these changes may influence toxicity outcomes.

FutureToxIV progress to maturity, Predictive Toxicology for Healthy Children, November 14–16, 2018, Crystal City, Virginia

Future tox 4 image.pngThe prevalence of adverse children’s health outcomes in the US demonstrates a growing need for research to understand the impact of environmental factors on human development and for actionable solutions to ensure well-being across lifestages. This meeting will focus on bringing together basic, clinical, and regulatory scientists to bridge the translation from historical approaches to Tox21 implementation relative to risk assessment and regulatory decision-making for matters pertaining to developmental health, lifestage progression, and the human reproductive cycle.